Robert E Hoffman is an accomplished executive in the biotechnology sector, currently serving as President and Chief Executive Officer of Kintara Therapeutics, Inc. (NASDAQ: KTRA) and Chairman of the Board for the same organization. In addition to these roles, Hoffman holds board memberships at ASLAN Pharmaceuticals, FibroGenesis, and Antibe Therapeutics Inc. Education includes a degree from St. Bonaventure University, completed between 1984 and 1988.
This person is not in any teams
This person is not in any offices